Advances in magnetic resonance imaging: Applications in body imaging

Cancer Investigation

Volumn 16, Issue 6, 1998, Pages 413-420

  Winston, Corinne B ^a,b   Schwartz, Lawrence H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADNEXA DISEASE; ADRENAL DISEASE; DIAGNOSTIC IMAGING; ENDOMETRIUM CANCER; HUMAN; LIVER DISEASE; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER;

EID: 0031904619     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809115782     Document Type: Review

References (40)

1. Stack JP, Antoun NM, Jenkins JPR, et al: Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology 30:145-154, 1988.
2. Takemoto K, Matsumura Y, Hashimoto H, et al: MR imaging of intraspinal tumors-Capability in histological differentiation and compartmentalization of extramedullary tumors. Neuroradiology 30:303-309, 1988.
3. Russell EJ, Geremia GK, Johnson CE, et al: Multiple cerebral métastases: Detectability with Gd-DTPA-enhanced MR imaging. Radiology 165:609-617, 1987.
4. Westbroolk C, Kraut C: In: MRI in Practice, Oxford, Blackwell Scientific Publications, 1993, pp 1-46.
5. Mitchell DG, Burk DL, Vmitski S, et al: The biophysical basis of tissue contrast in extracranial MR imaging. AJR 149:831-837, 1987.
6. Smith RC, Reinhold C, McCauley TR, et al: Multicoil high-resolution fast spin-echo MR imaging of the female pelvis. Radiology 184:671-675, 1992.
7. McCauley TR, McCarthy S, Lange R: Pelvic phased array coil: imaging quality assessment for spin-echo MR imaging. Magn Reson Imaging 10:513-522, 1992.
8. Kier R: Magnetic resonance imaging of the uterus. MRI Clin North Am 2:189-210, 1994. ,
9. DiSaia PJ, Creasman \VT: Clinical Gynecologic Oncology, 4th ed., St. Louis, CV Mosby, 1993, pp 58-125.
10. Hricak H, Powell CB, Yu KK, et al: Invasive cervical carcinoma. Role of MR imaging in pretreatment work-up cost minimization and diagnostic efficacy analysis. Radiology 198:403109, 1996.
11. Mezrich R, Magnetic resonance imaging-Applications in uterine cervical cancer. MRI Clin North Am 2:211-243, 1994.
12. Kim SH, Choi BI, Man JK, et al: Preoperative staging of uterine cervical carcinoma: Comparison of CT and MR in 99 patients. J Comput Assist Tomogr 17:633-640, 1993.
13. Hricak H, Lacey CG, Sandles LG, et al: Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology 166:623-631, 1988.
14. Togashi K, Nishimura K, Sagon T, et al: Carcinoma of the cervix: Staging with MR imaging. Radiology 171:245-251, 1989.
15. Boronow RC, Morrow CP, Creasnan WT: Surgical staging in edometrial cancer; Clinical-pathological findings of a prospective study. Obstet Gynecol 63:825-832, 1984.
16. Posniak HV, Olson MC, Dudiak C, et al: MR imaging of uterine carcinoma: Correlation with clinical and pathologic findings. Radiographies 10:15-27, 1990.
17. Weinreb JC, Barkoff ND, Megibow A, et al: The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. AJR 154:295-299, 1990.
18. Outwater EK, Schlebler M: Magnetic resonance imaging of the ovary. MRI Clin North Am 2:245-273, 1994.
19. Soyer P, Clement de Givry S, Gueye C, et al: Detection of focal hepatic lesions with MR imaging: prospective comparison of T2weighted fast spin echo with and without fat suppression, T2weighted breathhold fast spin-echo, and gadolinium chelateenhanced 3D gradient recalled imaging. AJR 166:1115-1121, 1996.
20. Ros PR: Malignant Liver Tumors. In: Textbook of Gastrointestinal Radiology, Vol. 2, edited by RM Gore, MS Levine, I Laufer, Philadelphia, WB Saunders, 1994, pp 1897-1946.
21. Schnall M: Magnetic resonance imaging of focal liver lesions. Semin Roentgenol 30:347-361, 1995.
22. Winston SW, Herfkens RJ, Jeffrey RB, et al: Dynamic breathhold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangioma from malignancies at 1.5 Tesla. Radiology 189:863-870, 1993.
23. Outwater E, Tomaszewski JE, Daly JM: Hepatic colorectal métastases: Correlation of MR imaging and pathologic appearance. Radiology 180:327-322, 1991.
24. Mitchell DG, Rubin R, Siegelman ES, et al: Hepatocellular carcinoma within siderotic regenerative nodules: Appearance as a nodule within a nodule on MR images. Radiology 178:101-103, 1991.
25. Mitchell DG: Focal manifestations of diffuse liver disease at MR imaging. Radiology 185:1-11, 1992.
26. Ros PR, Freeny PC, Harms SE, et al: Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy on the detection of focal hepatic lesions. Radiology 196:481488, 1995.
27. Vogl TJ, Hammerstingl R, Schwanz W. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198:881-887, 1996.
28. Glazer HS, Weyman PJ, Sagel-SS, et ah Nonfunctioning adrenal masses: Incidental discovery on computed tomography. AJR 139:81-85, 1982.
29. Mitchell DO, Crovello M, Matteucci T., et al: Benign adrenocortical masses: Diagnosis with chemical shift MR imaging. Radiology 185:345-351, 1992.
30. Tsushima Y, Ishizaka H, Matsumoto M: Adrenal masses: Differentiation with chemical shift, fast low-angle shot MR Imaging. Radiology 186:705-709, 1993.
31. Schwarte LH, Panicek DM, Koutcher JA, et al: Adrenal masses in patients with malignancy: Prospective comparison of echo-planar, fast spin echo, and chemical-shift MR imaging. Radiology 197:42125, 1995.
32. Lee MJ, Mayo-Smith W, Hahn PF, et al: State-of-the-art MR imaging of the adrenal gland. Radiographies 14:1015-1027, 1994.
33. Winston CB, Mitchell DG, Cutwater EK, et al: Pancreatic signal intensity on Tl-weighted fat saturation MR images: Clinical correlation. J Magn Reson Imaging 5:267-271, 1995.
34. Semelka RC, Asher SM: MR imaging of the pancreas. Radiology 188:593-602, 1993.
35. Gabata T, Matsui O, Kadoya M, et al: Small pancreatic adenocar-cinomas: Efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology 193:683-688, 1994.
36. Muller MG, Meyenberger C, Bertschinger P, et al: Pancreatic tumors: Evaluation with endoscopie US, CT, and MR imaging. Radiology 190:745-751, 1994.
37. Megibow AJ, Zhou XH, Rotterdam, et al: Pancreatic adenocarcinoma: CT versus MR inaging in the evaluation of resectability: Report of the Radiology Diagnostic Oncology Group. Radiology 195:327-332, 1995.
38. Mitchell DG, Cruvella M, Eschleman DJ, et al: MRI of pancreatic gastrinomas: J Comput Assist Tomogr 16:583-585, 1992.
39. Panicek DM, Gatsonis C, Rosenthal DI, et al: CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 202:237-246, 1997.
40. Jelinek JS, Kransdorf MJ, Utz JA, et al: Imaging of pigmented villonodular synovitis with emphasis on MR imaging. AJR 152:337-342, 1989.